CONTI, ELISA
CONTI, ELISA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?
2008 Galimberti, G; Conti, E; Zini, M; Piazza, F; Fenaroli, F; Isella, V; Facheris, M; Perlangeli, V; Antolini, L; De Filippi, F; Ferrarese, C
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients
2010 Conti, E; Galimberti, G; Tremolizzo, L; Masetto, A; Cereda, D; Zanchi, C; Piazza, F; Casati, M; Isella, V; Appollonio, I; Ferrarese, C
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients
2010 Conti, E; Galimberti, G; Piazza, F; Raggi, M; Ferrarese, C
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid
2011 Tironi, M; Conti, E; Galimberti, G; Zoia, C; Tremolizzo, L; Ferrarese, C
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease
2011 Galimberti, G; Conti, E; Gregori, M; DA RE, F; Tironi, M; Masserini, M; Ferrarese, C
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis?
2011 Di Francesco, J; Piazza, F; Conti, E; Tremolizzo, L; Savoiardo, M; Ferrarese, C
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report
2011 DI FRANCESCO, J; Brioschi, M; Brighina, L; Ruffmann, C; Saracchi, E; Costantino, G; Galimberti, G; Conti, E; Curtò, N; Marzorati, L; Remida, P; Tagliavini, F; Savoiardo, M; Ferrarese, C
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease?
2012 DA RE, F; Conti, E; Galimberti, G; Gregori, M; Salvati, E; Tironi, M; Stefanoni, G; Rosa, M; Riva, C; Masserini, M; Ferrarese, C
Myocyte enhancer factor-2D expression in ALS lymphomonocytes
2012 Tremolizzo, L; Sala, G; Conti, E; Arosio, A; RODRIGUEZ MENENDEZ, V; Ferrarese, C
Whole-blood global DNA methylation and phenotypic variability in ALS
2012 Tremolizzo, L; Conti, E; Sala, G; Cecchi, M; Airoldi, L; Pastorelli, R; Messina, P; Pupillo, E; Beghi, E; Ferrarese, C; Eurals,
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors
2012 Tironi, M; Conti, E; Santarone, M; Galimberti, G; Zoia, C; Tremolizzo, L; Ferrarese, C
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid
2012 Tremolizzo, L; Sala, G; Conti, E; RODRIGUEZ MENENDEZ, V; Lunetta, C; Fogli, A; Penco, S; Ferrarese, C; Corbo, M
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types
2012 Tremolizzo, L; Conti, E; Appollonio, I; Ferrarese, C
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients
2012 Tremolizzo, L; DI FRANCESCO, J; Rodriguez Menendez, V; Riva, C; Conti, E; Galimberti, G; Ruffmann, C; Ferrarese, C
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease
2012 Piazza, F; Galimberti, G; Conti, E; Isella, V; Perlangeli, M; Speranza, T; Borroni, B; Pogliani, E; Padovani, A; Ferrarese, C
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity
2013 Zoia, C; Conti, E; Susani, E; Costantino, G; Cereda, D; Isella, V; Tremolizzo, L; Ferrarese, C
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS
2013 Conti, E; Zoia, C; Gregori, M; Susani, E; Tremolizzo, L; Brioschi, S; Masserini, M; Ferrarese, C
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor
2013 Tremolizzo, L; Conti, E; Zoia, C; Rizzo, C; GAMBACORTI PASSERINI, C; Weksler, M; Weksler, B; Ferrarese, C
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model
2013 DA RE, F; Conti, E; Zoia, C; Gregori, M; Susani, E; Costantino, G; Tremolizzo, L; Ferrarese, C
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression
2013 Zoia, C; Conti, E; Susani, E; Costantino, G; Cereda, D; Isella, V; Tremolizzo, L; Ferrarese, C